A new delivery trick pushed prime editing efficiency up to 2.9-fold without extra off-target edits

Key Findings

Prime editing corrected the Alzheimer's risk gene APOE4 in mouse brains — and cognition improved 🧠

• Using the latest prime editor (PE7), researchers converted the high-risk APOE4 allele to the lower-risk APOE3 variant in APP/APOE4 knock-in mice, reducing amyloid buildup, tau phosphorylation, and ERK pathway activation.
• Treated mice showed enhanced neuronal survival and better cognitive performance. The same correction worked in human neurons derived from a patient with one APOE4 copy, suppressing both amyloid and tau pathology.

A base edit to the liver slashed LDL cholesterol by ~40-50% — without touching the broken gene 💉

• Familial hypercholesterolemia caused by a non-functional LDL receptor has almost no good treatment options. Researchers bypassed the broken receptor entirely by base-editing ASGR1, a separate liver gene linked to low cholesterol in human genetic studies.
• In mice lacking a functional LDL receptor, 57.6% liver-wide editing produced roughly 95% protein suppression and sustained 40-50% reductions in LDL, total cholesterol, and triglycerides — with a clean safety profile.

A 'programmable cell killer' uses CRISPR to delete cells based on what RNA they're making ☠️

• CRISPR-Cas12a2 normally targets RNA, but researchers repurposed its RNA-triggered DNA-shredding activity to eliminate specific yeast and human cells expressing target transcripts — with single-nucleotide resolution and no detectable off-target killing.
• The system acts like a conditional self-destruct: cells expressing the wrong transcript get eliminated, others don't. The concept opens a path toward therapies that remove cells by identity rather than location.

One base editor built a fully off-the-shelf CAR T cell with four genes knocked out simultaneously 🔬

• Current CAR T manufacturing requires risky double-strand DNA breaks to knock genes in. The INSERT platform instead uses a base editor's nicking activity to drive precise insertion of cancer-targeting receptors (CD19, CD33, or mesothelin) while knocking out four immune-checkpoint genes in a single step — achieving over 95% quadruple knockout.
• No detectable translocations or significant off-target edits were found, and the engineered cells held up against multiple cancer lines including a 3D tumor model.

A phage protein destroys CRISPR's own mRNA while it's still being translated 🦠

• Phages and bacteria are locked in an arms race, and a newly described anti-CRISPR protein — AcrVA2 — found an unusual weapon: it triggers degradation of the Cas12 mRNA while the protein is still being made, coupling translation to destruction.
• The finding suggests nascent peptides (proteins mid-synthesis) may act as regulatory signals more broadly, a layer of gene control that's been largely overlooked across biology.

CRISPR screens mapped the stress survival network keeping kidney filtration cells alive 🫘

• Podocytes — the cells that filter blood in the kidney — are hard to replace once lost, and their failure drives chronic kidney disease. Researchers combined single-nucleus RNA sequencing from six types of kidney disease with a genome-wide CRISPR knockout screen to separate true survival drivers from bystander gene changes.
• Five validated targets (BST1, TALDO1, ATP6V1E1, PPP2R1A, CHL1) span metabolism, autophagy, and cell structure — suggesting podocyte survival depends on a coordinated network, not a single pathway.